128 related articles for article (PubMed ID: 17572707)
1. Donor-origin cell engraftment after intraosseous or intravenous bone marrow transplantation in a rat model.
Klimczak A; Unal S; Jankowska A; Coburn C; Siemionow M
Bone Marrow Transplant; 2007 Aug; 40(4):373-80. PubMed ID: 17572707
[TBL] [Abstract][Full Text] [Related]
2. Different routes of donor-derived hematopoietic stem cell transplantation for donor-specific chimerism induction across MHC barrier.
Siemionow MZ; Klimczak A; Unal S
Transplant Proc; 2005; 37(1):62-4. PubMed ID: 15808547
[TBL] [Abstract][Full Text] [Related]
3. Donor-specific tolerance in fully major histocompatibility major histocompatibility complex-mismatched limb allograft transplants under an anti-alphabeta T-cell receptor monoclonal antibody and cyclosporine A protocol.
Siemionow MZ; Izycki DM; Zielinski M
Transplantation; 2003 Dec; 76(12):1662-8. PubMed ID: 14688512
[TBL] [Abstract][Full Text] [Related]
4. Trafficking of donor-derived bone marrow correlates with chimerism and extension of composite allograft survival across MHC barrier.
Ozmen S; Ulusal BG; Ulusal AE; Izycki D; Yoder B; Siemionow M
Transplant Proc; 2006 Jun; 38(5):1625-33. PubMed ID: 16797371
[TBL] [Abstract][Full Text] [Related]
5. Role of thymus in operational tolerance induction in limb allograft transplant model.
Siemionow M; Izycki D; Ozer K; Ozmen S; Klimczak A
Transplantation; 2006 Jun; 81(11):1568-76. PubMed ID: 16770246
[TBL] [Abstract][Full Text] [Related]
6. Applications of bilateral vascularized femoral bone marrow transplantation for chimerism induction across the major histocompatibility (MHC) barrier: part II.
Klimczak A; Agaoglu G; Carnevale KA; Siemionow M
Ann Plast Surg; 2006 Oct; 57(4):422-30. PubMed ID: 16998336
[TBL] [Abstract][Full Text] [Related]
7. Long-term survival of composite hemiface/mandible/tongue allografts correlates with multilineage chimerism development in the lymphoid and myeloid compartments of recipients.
Kulahci Y; Klimczak A; Madajka M; Altuntas S; Siemionow M
Transplantation; 2010 Oct; 90(8):843-52. PubMed ID: 20697324
[TBL] [Abstract][Full Text] [Related]
8. Sirolimus promotes tolerance for donor and recipient antigens after MHC class II disparate bone marrow transplantation in rats.
Jäger MD; Liu JY; Timrott KF; Popp FC; Stoeltzing O; Lang SA; Piso P; Geissler EK; Schlitt HJ; Dahlke MH
Exp Hematol; 2007 Jan; 35(1):164-70. PubMed ID: 17198885
[TBL] [Abstract][Full Text] [Related]
9. New composite tissue allograft model of vascularized bone marrow transplant: the iliac osteomyocutaneous flap.
Nasir S; Klimczak A; Sonmez E; Bozkurt M; Gibson S; Siemionow M
Transpl Int; 2010 Jan; 23(1):90-100. PubMed ID: 19686290
[TBL] [Abstract][Full Text] [Related]
10. Mesenchymal stem cells prolong composite tissue allotransplant survival in a swine model.
Kuo YR; Goto S; Shih HS; Wang FS; Lin CC; Wang CT; Huang EY; Chen CL; Wei FC; Zheng XX; Lee WP
Transplantation; 2009 Jun; 87(12):1769-77. PubMed ID: 19543052
[TBL] [Abstract][Full Text] [Related]
11. Development of donor-specific chimerism and tolerance in composite tissue allografts under alphabeta-T-cell receptor monoclonal antibody and cyclosporine a treatment protocols.
Ozer K; Izycki D; Zielinski M; Siemionow M
Microsurgery; 2004; 24(3):248-54. PubMed ID: 15160385
[TBL] [Abstract][Full Text] [Related]
12. A new method of bone marrow transplantation leads to extension of skin allograft survival.
Siemionow M; Ozer K; Izycki D; Unsal M; Klimczak A
Transplant Proc; 2005 Jun; 37(5):2309-14. PubMed ID: 15964406
[TBL] [Abstract][Full Text] [Related]
13. Prevention of graft-versus-host disease by intra-bone marrow injection of donor T cells.
Fukui J; Inaba M; Ueda Y; Miyake T; Hosaka N; Kwon AH; Sakaguchi Y; Tsuda M; Omae M; Kamiyama Y; Ikehara S
Stem Cells; 2007 Jun; 25(6):1595-601. PubMed ID: 17446564
[TBL] [Abstract][Full Text] [Related]
14. Long-term observation after simultaneous lung and intra-bone marrow-bone marrow transplantation.
Kaneda H; Adachi Y; Saito Y; Ikebukuro K; Machida H; Suzuki Y; Minamino K; Zhang Y; Iwasaki M; Nakano K; Koike Y; Wang J; Imamura H; Ikehara S
J Heart Lung Transplant; 2005 Sep; 24(9):1415-23. PubMed ID: 16143265
[TBL] [Abstract][Full Text] [Related]
15. Donor bone marrow in laryngeal transplantation: results of a rat study.
Khariwala SS; Dan O; Lorenz RR; Klimczak A; Siemionow M; Strome M
Am J Otolaryngol; 2008; 29(4):242-9. PubMed ID: 18598835
[TBL] [Abstract][Full Text] [Related]
16. The reversed paradigm of chimerism induction: Donor conditioning with recipient-derived bone marrow cells as a novel approach for tolerance induction in vascularized composite allotransplantation.
Siemionow M; Rampazzo A; Gharb BB; Cwykiel J; Klimczak A; Madajka M; Nasir S; Bozkurt M
Microsurgery; 2016 Nov; 36(8):676-683. PubMed ID: 26990895
[TBL] [Abstract][Full Text] [Related]
17. Mixed chimerism achieved by a nonlethal conditioning regimen induces donor-specific tolerance to lung allografts.
Li S; Salgar SK; Kurimoto Y; Yousem S; Pham SM
J Surg Res; 2008 May; 146(2):289-97. PubMed ID: 18314139
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of transient treatment with FK506 in the early phase on cyclophosphamide-induced bone marrow chimerism and transplant tolerance across MHC barriers.
Okayama J; Ko S; Kanehiro H; Kanokogi H; Nakajima Y
J Surg Res; 2006 Jun; 133(2):61-8. PubMed ID: 16376943
[TBL] [Abstract][Full Text] [Related]
19. Alloantigen-pulsed host dendritic cells induce T-cell regulation and prolong allograft survival in a rat model of hindlimb allotransplantation.
Kuo YR; Huang CW; Goto S; Wang CT; Hsu LW; Lin YC; Yang KD; Chen CL; Lee WP
J Surg Res; 2009 May; 153(2):317-25. PubMed ID: 19101689
[TBL] [Abstract][Full Text] [Related]
20. Lack of correlation between an assay used to determine early marrow allograft rejection and long-term chimerism after murine allogeneic bone marrow transplantation: effects of marrow dose.
Koh CY; Welniak LA; Murphy WJ
Biol Blood Marrow Transplant; 2005 Apr; 11(4):252-9. PubMed ID: 15812390
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
